Jove
Visualize
Contact Us

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K
Tumor Progression02:07

Tumor Progression

7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Cancer02:18

Cancer

55.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

6.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer.

Cancer discovery·2026
Same journal

DNA, Peptide Vaccines Advance Against GBM.

Cancer discovery·2026
Same journal

AKR1C1 Promotes ADC Resistance by Altering Uptake and Export.

Cancer discovery·2026
Same journal

Acquisition of Centromeric Features Supports Telomere Integrity.

Cancer discovery·2026
Same journal

Germline CDK12 variants in aggressive prostate cancer.

Cancer discovery·2026
Same journal

Type II JAK2 Inhibitor Gets Off to a Strong Start.

Cancer discovery·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 2, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

10.6K

Chromosome Instability Drives Tumor Evolution

    Cancer Discovery
    |May 11, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Chromosomal instability and tumor heterogeneity in non-small cell lung cancer drive recurrence. Bespoke ctDNA tests enabled early detection of relapse and metastasis in a TRACERx trial study.

    More Related Videos

    Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes
    05:22

    Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes

    Published on: April 13, 2018

    11.1K
    Chromosome Replicating Timing Combined with Fluorescent In situ Hybridization
    17:14

    Chromosome Replicating Timing Combined with Fluorescent In situ Hybridization

    Published on: December 10, 2012

    14.6K

    Related Experiment Videos

    Last Updated: Mar 2, 2026

    Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
    08:29

    Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

    Published on: May 14, 2018

    10.6K
    Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes
    05:22

    Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes

    Published on: April 13, 2018

    11.1K
    Chromosome Replicating Timing Combined with Fluorescent In situ Hybridization
    17:14

    Chromosome Replicating Timing Combined with Fluorescent In situ Hybridization

    Published on: December 10, 2012

    14.6K

    Area of Science:

    • Oncology
    • Genetics
    • Cancer Research

    Background:

    • Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality.
    • Understanding the mechanisms driving NSCLC recurrence and metastasis is crucial for improving patient outcomes.
    • Tumor heterogeneity and chromosomal instability are increasingly recognized as key factors in cancer progression.

    Purpose of the Study:

    • To investigate the role of chromosomal instability and tumor heterogeneity in driving disease recurrence in non-small cell lung cancer.
    • To develop and validate novel methods for early detection of relapse and metastasis.
    • To leverage genetic diversity insights for improved cancer monitoring.

    Main Methods:

    • Prospective study design involving patients with non-small cell lung cancer undergoing treatment.
    • Comprehensive genomic profiling through sequencing of multiple regions of the primary tumor.
    • Development of personalized circulating tumor DNA (ctDNA) tests tailored to individual tumor profiles.
    • Utilizing ctDNA analysis for early detection of minimal residual disease, relapse, and metastasis.

    Main Results:

    • Significant correlation identified between chromosomal instability, tumor heterogeneity, and disease recurrence in NSCLC patients.
    • Bespoke ctDNA tests demonstrated high sensitivity and specificity for early detection of relapse.
    • Early detection of metastasis was achieved through serial monitoring of ctDNA levels.
    • Genetic diversity within primary tumors was a key determinant of treatment response and recurrence patterns.

    Conclusions:

    • Chromosomal instability and tumor heterogeneity are critical drivers of non-small cell lung cancer recurrence.
    • Personalized ctDNA testing represents a powerful tool for early detection of relapse and metastasis.
    • The TRACERx trial findings underscore the importance of genomic profiling for guiding NSCLC management and improving patient survival.